Showing 1 - 13 results of 13 for search 'Javier Pinilla‐Ibarz', query time: 0.05s
Refine Results
-
1
-
2
-
3
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model by Kamira Maharaj, Kamira Maharaj, John J. Powers, Melanie Mediavilla-Varela, Alex Achille, Wael Gamal, Wael Gamal, Steven Quayle, Simon S. Jones, Eva Sahakian, Eva Sahakian, Javier Pinilla-Ibarz, Javier Pinilla-Ibarz
Published 2020-11-01
Article -
4
T315I-mutated myeloid sarcoma by Yumeng Zhang, David M. Swoboda, Aditya Grover, Lisa Nodzon, Ling Zhang, Javier Pinilla-Ibarz
Published 2019-01-01
Article -
5
-
6
-
7
PB1945: PATIENT PERSPECTIVES ON CLL TREATMENT SIDE EFFECTS: A SUB-ANALYSIS OF THE VOICE SURVEY by Constantine Tam, Javier Pinilla-Ibarz, Volkan Karakus, Miguel Pavlovsky, Stephan Stilgebauer, Martin Šimkovič, Ana Cristina Fenili, Miguel Augusto Miroli, Carolina Garcia Castillo, Kathryn Huntley, Catherine Moura, Fernando Piotrowski, Mervat Mattar
Published 2023-08-01
Article -
8
P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE:... by Martin C. Müller, Jorge Cortes, Charles Chuah, Daniel Deangelo, Michael Deininger, François Guilhot, Timothy Hughes, Franck Emmanuel Nicolini, Javier Pinilla-Ibarz, Delphine Rea, Gianantonio Rosti, Neil P. Shah, Moshe Talpaz, Vickie Lu, Thihan Padukkavidana, Hagop Kantarjian
Published 2023-08-01
Article -
9
Electrocardiographic Changes Associated With Ibrutinib Exposure by Michael G. Fradley MD, Allan Welter-Frost MD, Matthew Gliksman BS, Josephine Emole MD, Federico Viganego MD, Dae Hyun Lee MD, Bijal Shah MD, Julio C. Chavez MD, Javier Pinilla-Ibarz MD, PhD, Matthew B. Schabath PhD
Published 2020-06-01
Article -
10
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee by James L. Januzzi, Joseph M. Garasic, Scott E. Kasner, Vickie McDonald, Mark C. Petrie, Jonathan Seltzer, Michael Mauro, Kevin Croce, Ellin Berman, Michael Deininger, Andreas Hochhaus, Javier Pinilla-Ibarz, Franck Nicolini, Dong-Wook Kim, Daniel J. DeAngelo, Hagop Kantarjian, Jing Xu, Tracey Hall, Shouryadeep Srivastava, Daniel Naranjo, Jorge Cortes
Published 2022-01-01
Article -
11
Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel by Aasha I. Hoogland, Reena V. Jayani, Aaron Collier, Nathaly Irizarry‐Arroyo, Yvelise Rodriguez, Michael D. Jain, Margaret Booth‐Jones, Kelly A. Hyland, Brian W. James, Anna Barata, Christina A. Bachmeier, Julio C. Chavez, Farhad Khimani, Gabriel S. Krivenko, Aleksandr Lazaryan, Hien D. Liu, Taiga Nishihori, Javier Pinilla‐Ibarz, Bijal D. Shah, Muneer Abidi, Frederick L. Locke, Heather S. L. Jim
Published 2021-03-01
Article -
12
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia by Ehab Atallah, Charles A. Schiffer, Kevin P. Weinfurt, Mei-Jie Zhang, Jerald P. Radich, Vivian G. Oehler, Javier Pinilla-Ibarz, Michael W. N. Deininger, Li Lin, Richard A. Larson, Michael J. Mauro, Joseph O. Moore, Ellen K. Ritchie, Neil P. Shah, Richard T. Silver, Martha Wadleigh, Jorge Cortes, James Thompson, Jessica Guhl, Mary M. Horowitz, Kathryn E. Flynn
Published 2018-04-01
Article -
13
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma by AGM Mostofa, Allison Distler, Mark B. Meads, Eva Sahakian, John J. Powers, Alexandra Achille, David Noyes, Gabriela Wright, Bin Fang, Victoria Izumi, John Koomen, Rupal Rampakrishnan, Tuan P. Nguyen, Gabriel De Avila, Ariosto S. Silva, Praneeth Sudalagunta, Rafael Renatino Canevarolo, Maria D. Coelho Siqueira Silva, Raghunandan Reddy Alugubelli, Hongyue A. Dai, Amit Kulkarni, William S. Dalton, Oliver A. Hampton, Eric A. Welsh, Jamie K. Teer, Alexandre Tungesvik, Kenneth L. Wright, Javier Pinilla-Ibarz, Eduardo M. Sotomayor, Kenneth H. Shain, Jason Brayer
Published 2021-12-01
Article